U.S. Peptide Synthesis Market Size & Outlook, 2025-2033
- Biotechnology
- Proteomics & Protein Analysis
- Peptide Synthesis Market Outlook
- Proteomics & Protein Analysis
Global Market
Related Markets
Ask a question about the peptide synthesis market
U.S. peptide synthesis market highlights
- The U.S. peptide synthesis market generated a revenue of USD 320.7 million in 2024 and is expected to reach USD 604.1 million by 2033.
- The U.S. market is expected to grow at a CAGR of 7.5% from 2025 to 2033.
- In terms of segment, reagents & consumables was the largest revenue generating product in 2024.
- Equipment is the most lucrative product segment registering the fastest growth during the forecast period.
Peptide synthesis market data book summary
| Market revenue in 2024 | USD 320.7 million |
| Market revenue in 2033 | USD 604.1 million |
| Growth rate | 7.5% (CAGR from 2025 to 2033) |
| Largest segment | Reagents & consumables |
| Fastest growing segment | Equipment |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Consumables, Equipment, Service |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GenScript, Bachem Holding AG, Biotage, Creative Diagnostics, PolyPeptide Group AG, Syngene, Lonza |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.4% of the global peptide synthesis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. peptide synthesis market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 604.1 million by 2033.
The peptide synthesis market in the U.S. dominated the North American peptide synthesis market in 2024. Several key factors aid market growth in the country. The increasing prevalence of chronic diseases such as diabetes and obesity drives demand for peptide-based therapeutics. Investments in research and development of personalized medicines and advanced synthesis technologies also contribute to the market’s growth.
For instance, in July 2024, CordenPharma announced an investment to expand its peptide manufacturing capabilities in the U.S. and Europe. The U.S. expansion at the Colorado site includes constructing a new large-scale facility and increasing manufacturing capacity to meet the growing demand for GLP-1 peptides. These initiatives aim to position the U.S. as a leader in the peptide synthesis market.
No credit card required*
Publish Date: Jun 23, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Synthesis Market Scope
Peptide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| PolyPeptide Group AG | View profile | 1,273 | Neuhofstrasse 24, Baar, Zug, Switzerland, 6340 | www.polypeptide.com |
| Bachem Holding AG | View profile | 2,006 | Hauptstrasse 144, Bubendorf, Switzerland, 4416 | www.bachem.com |
| Creative Diagnostics | View profile | 51-100 | New York, New York, United States, North America | www.creative-diagnostics.com |
| Syngene | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | www.syngeneintl.com |
| Biotage | View profile | 501-1000 | Uppsala, Uppsala Lan, Sweden, Europe | www.biotage.com |
| GenScript | View profile | - | - | - |
| Lonza | View profile | - | - | - |
U.S. Peptide Synthesis Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Peptide Synthesis Market Outlook will help companies and investors design strategic landscapes.
Reagents & Consumables was the largest segment with a revenue share of 52.73% in 2024.
Horizon Databook has segmented the U.S. peptide synthesis market based on reagents & consumables, equipment, service covering the revenue growth of each sub-segment from 2021 to 2033.
The peptide synthesis market in the U.S. dominated the North American peptide synthesis market in 2024. Several key factors aid market growth in the country. The increasing prevalence of chronic diseases such as diabetes and obesity drives demand for peptide-based therapeutics. Investments in research and development of personalized medicines and advanced synthesis technologies also contribute to the market’s growth.
For instance, in July 2024, CordenPharma announced an investment to expand its peptide manufacturing capabilities in the U.S. and Europe. The U.S. expansion at the Colorado site includes constructing a new large-scale facility and increasing manufacturing capacity to meet the growing demand for GLP-1 peptides. These initiatives aim to position the U.S. as a leader in the peptide synthesis market.
- U.S. Peptide Synthesis Market Product Outlook (Revenue, USD Million , 2021-2033)
- Reagents & Consumables
- Equipment
- Service
- U.S. Peptide Synthesis Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- U.S. Peptide Synthesis Market Application Outlook (Revenue, USD Million , 2021-2033)
- Therapeutics
- Research
- Diagnosis
- U.S. Peptide Synthesis Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- CDMOs & CROs
- Academic & Research Institutes
Reasons to subscribe to Peptide Synthesis Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Peptide Synthesis Market Outlook databook
- Our clientele includes a mix of Peptide Synthesis Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Peptide Synthesis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Peptide Synthesis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Peptide Synthesis Market, 2021-2033 (US$M)
U.S. peptide synthesis market statistics, by product, 2021-2033 (US$M)
